EMPAGLIGLOZIN helps to treat type 2 diabetes. It helps to control blood sugar. Treatment is combined with diet and exercise. Compare SGLT2 inhibitors.

Jardiance Latest News

Get the latest updates on this drug from the GoodRx medical team

Jardiance for Diabetes Reduces Deaths from Heart Disease

Elizabeth Davis - September 17, 2015

Good news! In a just-published study, Jardiance (empagliflozin) for type 2 diabetes has been shown to reduce deaths from cardiovascular disease.

The results are impressive. Comparing Jardiance to a placebo, the study showed a 38% reduction in the risk of death from a cardiovascular cause (3.7% with Jardiance vs 5.9% with placebo). Jardiance was also shown to reduce the risk of any cardiovascular event (heart attack, stroke, or death) by 14%, and to reduce the risk of death from all causes by 32%. See More

Synjardy: Newly Approved for Type 2 Diabetes

The GoodRx Pharmacist - September 02, 2015

According to the 2014 National Diabetes Statistics Report from the CDC, 29.1 million people or 9.3% of the United States population has either type 1 or type 2 diabetes. That means that almost 1 in 11 Americans have diabetes!

With so many people affected, new medications are constantly being developed—especially to help treat type 2 diabetes, the most common form.

Synjardy (empagliflozin/metformin) is the newest of these drugs to receive FDA approval for the treatment of type 2 diabetes, on August 27, 2015. See More

Ketoacidosis Warning Issued for New Diabetes Meds

The GoodRx Pharmacist - May 21, 2015

On May 15, 2015, the FDA issued a warning for the newest class of diabetes medications, SGLT2 inhibitors.

According to the FDA, the medications in this class may lead to a serious and life-threatening condition known as ketoacidosis.

Which medications are considered SGLT2 inhibitors?

These medications also contain SGLT2 inhibitors in combination with other active ingredients:

What should I do if I am taking one of these medications?

If you are taking one of the medications listed above DO NOT stop your medication without talking to your doctor. See More

New Diabetes Treatment Approved: Jardiance

The GoodRx Pharmacist - August 08, 2014

Jardiance (empagliflozin) was approved by the FDA on August 1, 2014 for the treatment of type 2 diabetes.

What type of medication is Jardiance?
Jardiance is part of a new class of medications recently approved by the FDA, Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors.

How does Jardiance work?

It works with the body’s natural process of urination to help remove more excess sugar from the body rather than allowing it to be reabsorbed by your kidneys. See More

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.